Neuregulin-1 (NRG1): An Emerging Tumor-Agnostic Target

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
NRG1: An Emerging Tumor-Agnostic Target

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Changing the Course of Outcomes in NSCLC: Immunotherapy Approaches for Early-Stage Disease

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Exploring the Abundance of Biomarkers in Lung Cancer: Current Applications and Future Prospects for Precision Medicine

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
ExpressPoints Exploring the Abundance of Biomarkers in Lung Cancer: Current Applications and Future Prospects for Precision Medicine

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Molecular Testing Overview and Biomarkers Predicting Response to Immune-Based Therapies in NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Predictive Biomarkers for Targeted Therapies in Advanced NSCLC: ALK and ROS1 Rearrangements, RET and NTRK Fusions, and KRAS G12C and METex14 Mutations

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Guidance on Treatment Selection for Patients With ES-SCLC

Content Format:

Tool

Credit Type:

--

Credits:

--
Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
ExpressPoints Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Emerging Predictive Biomarkers for Targeted Therapies in NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Lung Cancer: Independent Conference Coverage of the ASCO 2020 Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
ExpressPoints: Key Studies in Lung Cancer

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
My Take on the Recent Approval of Dual Immune Checkpoint Inhibition for Advanced NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2020: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Immunotherapy Combinations for Lung Cancers: Challenges and Opportunities of Rapidly Evolving Treatments

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
My Thoughts on the Evolving Role of Immunotherapy for SCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--